✦ LIBER ✦

EGF receptor targeting in therapy-resistant human tumors

✍ Scribed by Mathias Schmidt; Rosemarie B Lichtner

Book ID: 117764471
Publisher: Elsevier Science
Year: 2002
Tongue: English
Weight: 253 KB
Volume: 5
Category: Article
ISSN: 1368-7646
DOI: 10.1016/s1368-7646(02)00004-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

638 Acquired resistance to EGF receptor-

638 Acquired resistance to EGF receptor-targeted cancer therapy

✍ Y. Lu; R. Luwor; K. Liang; X. Li; G. Mills; J. Mendelsohn; Z. Fan 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 284 KB

The EGF receptor family as targets for c

The EGF receptor family as targets for cancer therapy

✍ Mendelsohn, John; Baselga, Jose 📂 Article 📅 2000 🏛 Nature Publishing Group 🌐 English ⚖ 249 KB

Targeting the EGF receptor in breast can

Targeting the EGF receptor in breast cancer treatment

✍ C. Frederick LeMaistre; C. Meneghetti; L. Howes; C. K. Osborne 📂 Article 📅 1994 🏛 Springer US 🌐 English ⚖ 574 KB

Targeting EGF receptor variant III: tumo

Targeting EGF receptor variant III: tumor-specific peptide vaccination for malignant gliomas

✍ Del Vecchio, Catherine A; Li, Gordon; Wong, Albert J 📂 Article 📅 2012 🏛 Expert Reviews 🌐 English ⚖ 694 KB

In vivo evaluation of epidermal growth f

In vivo evaluation of epidermal growth factor (EGF) receptor density on human tumor xenografts using radiolabeled EGF and anti-(EGF receptor) mAb 425

✍ R. Senekowitsch-Schmidtke; Kurt Steiner; Jutta Haunschild; Sigrun Möllenstädt; R 📂 Article 📅 1996 🏛 Springer-Verlag 🌐 English ⚖ 482 KB

Development of ABX-EGF, a fully human an

Development of ABX-EGF, a fully human anti-EGF receptor monoclonal antibody, for cancer therapy

✍ Xiao-Dong Yang; Xiao-Chi Jia; Jose R.F. Corvalan; Ping Wang; C.Geoffrey Davis 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 187 KB

Overexpression of epidermal growth factor receptor (EGFr) has been demonstrated on many human tumors, and the increase in receptor expression levels has been linked with a poor clinical prognosis. Blocking the interaction of EGFr and the growth factors could lead to the arrest of tumor growth and po